UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:February 24,
BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more BioLineRx Charts.
BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more BioLineRx Charts.

Biolinerx Ltd. News

BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
Wednesday 17 April 2024 (2 weeks ago) • PR Newswire (US)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 16 February 2024 (2 months ago) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)
Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 30 December 2023 (4 months ago) • Edgar (US Regulatory)
Form F-3 - Registration statement by foreign private issuers
Saturday 30 December 2023 (4 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 21 December 2023 (4 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 12 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 20 November 2023 (5 months ago) • Edgar (US Regulatory)
Monday’s Wall Street Highlights: GM, Microsoft, Citigroup, Amazon, and more
Monday 20 November 2023 (5 months ago) • IH Market News
BioLineRx a conclu un accord de licence exclusive pour le motixafortide en Asie, sous les conseils de MSQ Ventures
Wednesday 1 November 2023 (6 months ago) • PR Newswire (Canada)

More Biolinerx Ltd. News Articles